Recombinant multi-species CALCA/CGRP/Procalcitonin protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CALCA/CGRP/Procalcitonin protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the peptide hormones calcitonin, calcitonin gene-related peptide and katacalcin by tissue-specific alternative RNA splicing of the gene transcripts and cleavage of inactive precursor proteins. Calcitonin is involved in calcium regulation and acts to regulate phosphorus metabolism. Calcitonin gene-related peptide functions as a vasodilator and as an antimicrobial peptide while katacalcin is a calcium-lowering peptide. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Aug 2014]
The Alternative Names of target: CA,CAL6,CALC,CALC1,CALCA,CCALCI,CGRP,CGRP-1,CGRP-I,CGRP-alpha,CGRP1,CT,Cal1,Calc,Calc1,Calca,Cgrp,Ct,Ctn,KC,PCT,Procalcitonin,RATCAL6,calcitonin

Target products collectionGo to CALCA/CGRP/Procalcitonin products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T93509-Ag-1/ GM-Tg-hg-T93509-Ag-2 Human CALCA/CGRP/Procalcitonin protein Human
GM-Tg-rg-T93509-Ag-1/ GM-Tg-rg-T93509-Ag-2 Rat CALCA/CGRP/Procalcitonin protein Rat
GM-Tg-mg-T93509-Ag-1/ GM-Tg-mg-T93509-Ag-2 Mouse CALCA/CGRP/Procalcitonin protein Mouse
GM-Tg-cynog-T93509-Ag-1/ GM-Tg-cynog-T93509-Ag-2 Cynomolgus/Rhesus macaque CALCA/CGRP/Procalcitonin protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T93509-Ag-1/ GM-Tg-felg-T93509-Ag-2 Feline CALCA/CGRP/Procalcitonin protein Feline
GM-Tg-cang-T93509-Ag-1/ GM-Tg-cang-T93509-Ag-2 Canine CALCA/CGRP/Procalcitonin protein Canine
GM-Tg-bovg-T93509-Ag-1/ GM-Tg-bovg-T93509-Ag-2 Bovine CALCA/CGRP/Procalcitonin protein Bovine
GM-Tg-equg-T93509-Ag-1/ GM-Tg-equg-T93509-Ag-2 Equine CALCA/CGRP/Procalcitonin protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T93509-Ag-1/ GM-Tg-hg-T93509-Ag-2; GM-Tg-rg-T93509-Ag-1/ GM-Tg-rg-T93509-Ag-2;
GM-Tg-mg-T93509-Ag-1/ GM-Tg-mg-T93509-Ag-2; GM-Tg-cynog-T93509-Ag-1/ GM-Tg-cynog-T93509-Ag-2;
GM-Tg-felg-T93509-Ag-1/ GM-Tg-felg-T93509-Ag-2; GM-Tg-cang-T93509-Ag-1/ GM-Tg-cang-T93509-Ag-2;
GM-Tg-bovg-T93509-Ag-1/ GM-Tg-bovg-T93509-Ag-2; GM-Tg-equg-T93509-Ag-1/ GM-Tg-equg-T93509-Ag-2
Products Name CALCA/CGRP/Procalcitonin protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CALCA/CGRP/Procalcitonin
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CALCA/CGRP/Procalcitonin protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.